Mucosal immunoadjuvant activity of the low toxic recombinant Escherichia coli heat-labile enterotoxin produced by Bacillus brevis for the bacterial subunit or component vaccine in pigs and cattle

Veterinary Immunology and Immunopathology

Volumn 87, Issue 3-4, 2002, Pages 291-300

  Yokomizo, Y ^a   Watanabe, F ^b   Imada, Y ^a   Inumaru, S ^a   Yanaka, T ^c   Tsuji, T ^d  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^b Higeta Shoyu Co Ltd   (Japan)

^c Kyoritsu Seiyaku Corporation   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Bacillus brevis; Mucosal adjuvant; Vaccine

Indexed keywords

BACTERIAL VACCINE; BORDETELLA BRONCHISEPTICA VACCINE; ERYSIPELOTHRIX VACCINE; ESCHERICHIA COLI VACCINE; IMMUNOLOGICAL ADJUVANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREVIBACILLUS BREVIS; CATTLE; COLOSTRUM; CONFERENCE PAPER; CONTROLLED STUDY; COW; ESCHERICHIA COLI; IMMUNIZATION; INFECTION; NONHUMAN; SALIVA; SWINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACILLUS; BACTERIAL TOXINS; BACTERIAL VACCINES; CATTLE; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; RECOMBINANT PROTEINS; SWINE; VACCINES, SUBUNIT;

BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; BOS TAURUS; BREVIBACILLUS BREVIS; ERYSIPELOTHRIX; ERYSIPELOTHRIX RHUSIOPATHIAE; ESCHERICHIA COLI;

EID: 0036089690     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(02)00055-7     Document Type: Conference Paper

References (20)

1. Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves
2. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants
3. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine
4. Role of Bordetella bronchiseptica sialic acid-binding heamagglutinin as a putative colonization factor
5. Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle
6. Protective effect of NaOH-extracted Erysipelothrix rhusiopathiae vaccine in pigs
7. Prevalence and characteristics of Shiga toxin-producing Escherichia coli from healthy cattle in Japan
8. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity
9. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
10. Human response to Escherichia coli O157:H7 infection: Antibodies to secreted virulence factors
11. Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk
12. Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells
13. Characterization of haemagglutinin from Bordetella bronchiseptica
14. Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence
15. Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: Identification of the region responsible for protective immunity
16. Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action
17. Bacillus brevis, a host bacterium for efficient extracellular production of useful proteins
18. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen
19. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
20. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system